In: Seminars in Immunopathology, 2015, vol. 37, no. 2, p. 83-96
|
In: Plos one, 2012, vol. 7, no. 4, p. e35485
Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we describe using systems analysis the biological and immunological characteristics of the attenuated vaccinia virus Ankara strain expressing the HIV-1...
|
In: Intensive Care Medicine, 2013, vol. 39, no. 4, p. 754-763
|
In: The Journal of Infectious Diseases, 2012, vol. 206, no. 3, p. 415-420
|
In: Journal of Infectious Diseases, 2011, vol. 204, no. 9, p. 1367-1374
|
In: Journal of Infectious Diseases, 2011, vol. 204, no. 5, p. 793-801
|
In: The Journal of Infectious Diseases, 2013, vol. 207, no. 2, p. 331-339
|
In: Clinical Infectious Diseases, 2005, vol. 41, no. Supplement_7, p. S513-S519
|
In: Journal of Infectious Diseases, 2012, vol. 205, no. 6, p. 944-954
|
In: The Journal of Infectious Diseases, 2003, vol. 187, no. Supplement_2, p. S385-S390
|